Interventions: Behavioral: 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS)
Sponsors: Government College University Faisalabad
Not yet recruiting
In high school, Ashley Delgado dreamed of becoming a doctor and one day buying her father a Rolls-Royce. “She wanted to heal people,” said her father, James Taylor. She had a high GPA, Taylor added, and did especially well in science and Latin.
In her mid-20s, Ashley suffered a leg injury and was prescribed OxyContin. The painkiller marked the beginning of a yearslong descent through addiction — from prescription opioids to methamphetamine, then heroin, and finally, fentanyl.
The Trump administration on Wednesday said it was announcing $700 million in “new funding” for mental health and addiction programs, with an emphasis on combating homelessness resulting from severe, untreated mental illness.
But behavioral health experts instantly cast doubt on the claim, identifying the $700 million not as new funding but as the long-awaited release of existing grants that Congress had previously authorized and that the federal government already planned to spend.
Nature Medicine, Published online: 16 June 2026; doi:10.1038/s41591-026-04513-4
Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
Given the prevalence of substance use disorder (SUD), elevated overdose death rates, and limited approved pharmacotherapies for SUD, new treatment approaches are necessary. Neuromodulation is a potential adjunctive treatment for SUD to reduce substance use and risk factors associated with drug use recurrence, such as craving. One form of neuromodulation, focused ultrasound (FUS), has significant potential given that it is non-invasive and capable of targeting subcortical structures implicated in the brain’s reward circuity with great precision.
Opioid use disorder is a chronic, relapsing condition that continues to rise worldwide. Naloxone (Narcan®), an opioid antagonist, reverses overdose but triggers strong negative affect. The neuronal circuits underlying these aversive effects remain unclear. We previously identified mu opioid receptor–expressing habenular neurons (Hb-MOR) as key encoders of negative emotional states and hypothesized that they also mediate naloxone aversion.